These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 7606196

  • 1. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
    Ranzani GN, Luinetti O, Padovan LS, Calistri D, Renault B, Burrel M, Amadori D, Fiocca R, Solcia E.
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
    [Abstract] [Full Text] [Related]

  • 2. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [Abstract] [Full Text] [Related]

  • 3. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [Abstract] [Full Text] [Related]

  • 4. Genetic pathways of two types of gastric cancer.
    Tahara E.
    IARC Sci Publ; 2004 Nov; (157):327-49. PubMed ID: 15055305
    [Abstract] [Full Text] [Related]

  • 5. p53 genetic abnormalities and P-glycoprotein expression in stump and primary gastric carcinomas.
    Oliver I, Lacueva J, Barberá V, Caldés T, Teruel A, Costa D, Medrano J, Pérez-Vázquez T, Quesada P, Ferragut J, Calpena R.
    Hepatogastroenterology; 2007 Mar; 54(74):377-81. PubMed ID: 17523278
    [Abstract] [Full Text] [Related]

  • 6. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
    Araya JC, Roa JC, Villaseca MA, Roa I, Guzmán P, Alvarado C, Melo A.
    Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
    [Abstract] [Full Text] [Related]

  • 7. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia.
    Szoke D, Molnár B, Solymosi N, Sipos F, Galamb O, Gyorffy A, Tulassay Z.
    Dig Liver Dis; 2009 Mar; 41(3):179-84. PubMed ID: 18567547
    [Abstract] [Full Text] [Related]

  • 8. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS.
    Cancer Res; 1994 Aug 15; 54(16):4342-6. PubMed ID: 8044781
    [Abstract] [Full Text] [Related]

  • 9. Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.
    Kang GH, Kim CJ, Kim WH, Kang YK, Kim HO, Kim YI.
    Lab Invest; 1997 Mar 15; 76(3):407-17. PubMed ID: 9121123
    [Abstract] [Full Text] [Related]

  • 10. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N.
    Hepatogastroenterology; 1999 Mar 15; 46(28):2648-53. PubMed ID: 10522058
    [Abstract] [Full Text] [Related]

  • 11. Genetic and epigenetic alterations in multistep carcinogenesis of the stomach.
    Yasui W, Yokozaki H, Fujimoto J, Naka K, Kuniyasu H, Tahara E.
    J Gastroenterol; 2000 Mar 15; 35 Suppl 12():111-5. PubMed ID: 10779229
    [Abstract] [Full Text] [Related]

  • 12. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ, Frierson H, Moskaluk CA, Harper JC, Roviello F, Jackson CE, El-Rifai W, Vindigni C, Tosi P, Powell SM.
    Mod Pathol; 2001 Oct 15; 14(10):942-9. PubMed ID: 11598162
    [Abstract] [Full Text] [Related]

  • 13. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM.
    Hepatogastroenterology; 1997 Oct 15; 44(14):604-9. PubMed ID: 9164544
    [Abstract] [Full Text] [Related]

  • 14. Analysis of p53 expression in precancerous and malignant gastric mucosa.
    Romiti A, Moretti A, Vecchione A, Muraro R, Feudi ML, Rinaldi V, Mancini R, Valli C, Mozzicafreddo A, Frati L, Tomao S.
    Oncol Rep; 1998 Oct 15; 5(1):109-13. PubMed ID: 9458303
    [Abstract] [Full Text] [Related]

  • 15. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY, Lin SR, Hsieh JS, Hsu CH, Huang YS, Huang TJ.
    Anticancer Res; 2001 Oct 15; 21(1B):513-20. PubMed ID: 11299797
    [Abstract] [Full Text] [Related]

  • 16. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
    Gomyo Y, Osaki M, Kaibara N, Ito H.
    Int J Cancer; 1996 May 29; 66(5):594-9. PubMed ID: 8647618
    [Abstract] [Full Text] [Related]

  • 17. [Multiple gene alterations involved in the processor of human gastric carcinogenesis].
    Lu Y, Li Z, Sun M.
    Zhonghua Yi Xue Za Zhi; 1995 Nov 29; 75(11):679-82, 710-1. PubMed ID: 8697090
    [Abstract] [Full Text] [Related]

  • 18. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype.
    Ohmura K, Tamura G, Endoh Y, Sakata K, Takahashi T, Motoyama T.
    Hum Pathol; 2000 Sep 29; 31(9):1031-5. PubMed ID: 11014567
    [Abstract] [Full Text] [Related]

  • 19. [High frequency mutation of p53 gene in human gastric cancer and precancerous lesions].
    Li Z, Lü Y.
    Zhonghua Zhong Liu Za Zhi; 1998 Mar 29; 20(2):90-3. PubMed ID: 10920952
    [Abstract] [Full Text] [Related]

  • 20. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
    Berloco P, Russo F, Cariola F, Gentile M, Giorgio P, Caruso ML, Valentini AM, Di Matteo G, Di Leo A.
    J Gastroenterol; 2003 Mar 29; 38(1):28-36. PubMed ID: 12560919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.